Relonchem Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Relonchem General Information

Description

Developer and supplier of healthcare pharmaceutical products intended to cater to the UK market. The company is engaged in the manufacturing and distribution of pharmaceutical products such as anti-diabetic, anti-hypertensive, anti-depressant, anti-cancer, anti-ulcerative, allergy relief, anti-viral and pain relief.

Contact Information

Website
www.relonchem.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Marksans Pharma
Primary Office
  • Cheshire House
  • Gorsey Lane
  • Widnes WA8 0RP
  • England, United Kingdom
+44 0151 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Relonchem Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Relonchem‘s full profile, request access.

Request a free trial

Relonchem Executive Team (2)

Name Title Board Seat Contact Info
John Ruprai Chief Executive Officer
Sathish Kumar K. J. Managing Director
To view Relonchem’s complete executive team members history, request access »

Relonchem Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial